Dr.Kallam Anji Reddy

Dr.Kallam Anji Reddy

Kallam Anji Reddy ( కళ్ళం అంజి రెడ్డి) (1940 - 15 March 2013) was an Indian entrepreneur in the pharmaceutical industry, the founder-chairman of Dr Reddy's Labs, which he established in 1984, and chairman of Dr Reddy’s Foundation (DRF), the corporate social responsibility arm of the group, established 1996. The Government of India, has honoured him with Padmabhushan for his contribution to the Indian Pharmaceutical industry. He was a member of the Indian Prime Minister's Council on Trade and Industry.

Kallam Anji Reddy
Born	1940 Tadepalli, Guntur district
Died	15 March 2013 (aged 72-73) Hyderabad, Andhra Pradesh
Cause of death	Liver cancer
Nationality	Indian
Occupation	Chairman, Dr Reddy's Labs
Known for	Dr. Reddy's Laboratories
Net worth	(USD) $1.39 Billion

Early Life and Education:

He spent his early years in the village Tadepalli, Guntur District in the banks of Krishna River, where his father grew turmeric. He studied in Anapothana ZPHS School in Nutakki from fifth to Tenth Class while living at the house his aunt, a sister of his mother.

Reddy after graduating from the local high school, went on to get his first Bachelor of science degree from Andhra Christian College or A.C. College at Guntur in 1958.Thereafter he, did his B.Sc.-Tech in Pharmaceuticals and Fine chemicals from Bombay University followed by a Ph.D. in chemical engineering from the National Chemical Laboratory, Pune in 1969.

Career:

He started his career in the state-owned PSU, Indian Drugs and Pharmaceuticals Limited (IDPL) (1969–1975), when he left the job to found Uniloids Ltd in 1976 of which was also the and managing director of till 1980, when he founded Standard Organics Limited, before founding Dr Reddy's Labs in 1984 with an initial capital of Rs 25 lakh (Rs 2.5 million). Over the years, it transformed Indian bulk drug industry from import-dependent in mid-80s to self-reliant in mid-90s and finally into the export-oriented industry.

Dr Reddy's Lab:

Dr. Reddy's Laboratories has been credited with turning the Indian bulk drug industry from dependence on imports in the mid 1980s to self reliance in the mid 1990s and finally into the export-oriented industry that it is today. It was the first company to take up drug discovery research in India (in 1993). In April 2001 Dr Reddy’s Labs became the first Asian pharmaceutical company outside Japan to be listed on the New York Stock Exchange. The company has revenues of $546 million (Rs.2,427 crore) during the fiscal year 2006 and is India’s second largest pharmaceutical company.

Death:

He died of liver cancer at 3:45 p.m. on March 15, 2013 at the Apollo Hospital in Hyderabad.He is survived by his wife, son and daughter.

Social Causes:

Naandi Foundation, a not-for-profit development institution that strives for eradication of poverty, has Dr Reddy as its founder. He was also founder and chairman of Dr. Reddy’s Foundation for Human and Social Development, a social arm of Dr. Reddy’s Labs.